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Abstract
Background: Malaria continues to be a great public health concern due to the significant mortality and morbidity
associated with the disease especially in developing countries. Microparticles (MPs), also called plasma membrane
derived extracellular vesicles (PMEVs) are subcellular structures that are generated when they bud off the plasma
membrane. They can be found in healthy individuals but the numbers tend to increase in pathological conditions
including malaria. Although, various studies have been carried out on the protein content of specific cellular derived
MPs, there seems to be paucity of information on the protein content of circulating MPs in malaria and their association
with the various signs and symptoms of the disease. The aim of this study was therefore to carry out proteomic analyses
of MPs isolated from malaria positive samples and compare them with proteins of MPs from malaria parasite culture
supernatant and healthy controls in order to ascertain the role of MPs in malaria infection.
Methods: Plasma samples were obtained from forty-three (43) malaria diagnosed patients (cases) and ten (10) healthy
individuals (controls). Malaria parasite culture supernatant was obtained from our laboratory and MPs were isolated from
them and confirmed using flow cytometry. 2D LC-MS was done to obtain their protein content. Resultant data were
analyzed using SPSS Ver. 21.0 statistical software, Kruskal Wallis test and Spearman’s correlation coefficient r.
Results: In all, 1806 proteins were isolated from the samples. The MPs from malaria positive samples recorded 1729
proteins, those from culture supernatant were 333 while the control samples recorded 234 proteins. The mean number
of proteins in MPs of malaria positive samples was significantly higher than that in the control samples. Significantly,
higher quantities of haemoglobin subunits were seen in MPs from malaria samples and culture supernatant compared
to control samples.
Conclusion: A great number of proteins were observed to be carried in the microparticles (MPs) from malaria samples
and culture supernatant compared to controls. The greater loss of haemoglobin from erythrocytes via MPs from malaria
patients could serve as the initiation and progression of anaemia in P.falciparum infection. Also while some proteins
were upregulated in circulating MPs in malaria samples, others were down regulated.
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Background
Microparticles (MPs) also called plasma membrane de-
rived extracellular vesicles (PMEVs) are a heterogeneous
group of small sub-membrane fragments or membrane
coated vesicles shed from the plasma membrane of vari-
ous cells during normal cellular activities like growth,
senescence, proliferation and apoptosis [1]. MPs carry
proteins, lipids and nucleic acids from host cells and are
means of intercellular communication and it has been
shown that analysis of MPs from blood samples can pro-
vide information about the state and progression of a
particular disease or condition [2].
Malaria is caused by five species of the genus Plasmo-
dium which is a unicellular protozoan parasite. The dis-
ease is a major cause of mortality and morbidity in
many developing countries especially in Sub-Saharan Af-
rica. It is estimated 3.4 billion people worldwide risk
being infected with malaria in 104 countries [3]. Compli-
cations associated with malaria infection particularly in
severe malaria include fever/chills, coagulopathy and an-
aemia among other symptoms. At the molecular level,
up-regulation of certain cytokines is also thought to re-
late to malaria associated high fever [4].
The degree of anaemia experienced in malaria does
not always correspond to the parasitaemia level [5]. This
is partly caused by a mild bone marrow suppression of
erythrocyte production and the collection of comple-
ment containing complexes on erythrocyte surfaces after
infection which promotes splenic removal of these eryth-
rocytes. Lysis of both infected and uninfected erythro-
cytes is also considered to be a contributing factor [5].
Severe malaria caused by Plasmodium falciparum is
considered to be associated with the dysregulation of the
coagulation system which include endothelial damage,
lower levels of anticoagulation and the release of pro-
coagulant MPs [6].
To this end, malaria has been associated with an
increase in the level of circulating plasma MPs and
plasma concentrations of endothelial MPs (EMPs) which
may be proportional to disease severity [7, 8]. The role
of infected erythrocyte-derived MPs in cellular
communication has been investigated but the protein
content (proteomic analysis) of MPs isolated in malaria
is yet to be explored [9]. Proteomic analysis on circulat-
ing MPs obtained from plasma of malaria positive blood
samples once explored will give a general idea of the
protein and protein groups borne by these MPs that
may influence the pathophysiology of malaria infection.
This study therefore sought to examine the protein
composition of plasma MPs of malaria samples and
comparing them with proteins of MPs from healthy
controls in order to explore their effect on the pathogen-
esis of malaria and the possible linkage of circulating
plasma MPs to malaria anaemia.
Existing literature indicate that elevated MPs levels
have been seen in cancer, sepsis, pulmonary hyperten-
sion, idiopathic thrombocytopenic purpura and athero-
sclerosis [10]. Researchers also contend that increased
endothelial microparticle level correlating with disease
severity has been seen in malaria [11]. Again studies in
mice models indicate that microparticles contributed to
induction of systemic inflammation [12, 13]. Others have
shown that MPs released after malaria infection which
are primarily erythrocyte-derived are capable of activat-
ing macrophage through toll-like receptors (TLR) and
may enhance infectivity as their count elevates and
investigations show they contain parasite components
some of which promote pathogen invasion of erythro-
cytes [14].
Regev-Rudzki et al. (2013) postulated that MPs re-
leased in malaria are also capable of activating the
blood–brain barrier which exacerbates inflammation
[15]. The perplexing feature of malarial anemia which is
increased clearance of uninfected erythrocytes can also
be attributed to the release of parasite antigens in MPs
during entry in erythrocytes. These erythrocyte-adhesive
proteins probably adhere to erythrocytes resulting in
IgG and complement binding which promotes their
elimination from peripheral circulation [16]. Further-
more, Schorey et al. stated that MPs released from P.
falciparum-infected cells are able to modulate hosts im-
mune response thereby impairing surveillance [17].
Proteomic analysis on circulating plasma MPs ob-
tained from plasma of malaria positive blood samples
once explored will give a general idea of the protein and
protein groups borne by these MPs thereby influencing
the pathophysiology of malaria infection. This study
seeks to examine the protein composition of plasma
MPs of malaria samples in order to explore their effect
on the pathogenesis of malaria and the possible linkage
of circulating plasma MPs to the anaemia.
Methods
Aim
The aim of this study was to carry out proteomic ana-
lyses of MPs isolated from malaria positive samples and
compare them with proteins of MPs from healthy
controls in order to ascertain the role of MPs in malaria
infection.
Design and setting
The study was a cross-sectional study conducted over a
2-year period, from May 2014 to June, 2016. The
samples were collected at the Sunyani Regional Hospital,
Ghana and all the laboratory work-up were carried out
at the Department of Molecular Medicine, Kwame
Nkrumah University of Science and Technology
(KNUST), Noguchi Memorial Institute for Medical
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Research (NMIMR) and the Proteomic and Flow cytom-
etry Core Facilities of the Indiana University School of
Medicine.
The characteristics of participants/materials
In all, fifty three (53) participants who were out-patients
were recruited into the study. There were 43 (23 males
and 20 females) cases and 10 (5 males and 5 females)
controls. The age range for controls was 28–47 years
while the age range for patients was 1 week to 62 years.
Processes
Sample collection
Convenience sampling was employed for this study.
Three milliliters (3 ml) of blood was collected from 43
laboratory diagnosed malaria patients. The parasite
density was confirmed using independently prepared
thick film. Control samples were obtained from 10 ap-
parently healthy individuals. The samples were catego-
rized into three (3): mild, moderate and high based on
the level of parasitaemia.
Thick film preparation
Briefly, 6 microlitres (6 μl) of blood was placed in the
middle of a glass slide for a thick film preparation using
the WHO standardized template. The slides were then
air-dried and subsequently stained as below.
Thick film staining and examination
The films were stained with 1:10 diluted Paskem®
Giemsa for 10 min, air dried and examined using the
Olympus ®CX 31 microscope (Tokyo, Japan). Parasite
count was calculated using the formula
Parasite count ¼ Number of parasite counted




Where 6000 is the assumed WBC count per 1 μl of
blood.
Purification of MPs from plasma
Briefly, EDTA-anticoagulated blood (3 mL) was centri-
fuged at 160 × g for 5 min, and plasma was stored at
−20 °C until further processing. During processing, sam-
ples were thawed and centrifuged at 4000 x g for 60 min
to obtain platelet-free plasma. The resultant supernatant
was then spun for 120 min at 19,000 × g to obtain the
microparticle pellet after the supernatant had been dis-
carded [18]. The MP pellet was then dissolved in 50 μl
of PBS and stored at −80 °C.
Flow cytometry analysis
All reagents used in the flow cytometry experiments
were from BD Biosciences unless otherwise stated. 50 μl
of phosphate buffered saline (PBS) was added to the
thawed MP pellet. Equal volume of Annexin V binding
buffer was added to label the MPs. Labeled plasma sam-
ples were analyzed on a BD FACSAriaTM flow cytometer.
MPs isolated from plasma were gated (Annexin V+)
based on their forward (FSC) and side (SSC) scatter
distribution as compared to the distribution of synthetic
0.7–0.9 μm SPHERO™ Amino Fluorescent Particles
(Spherotech Inc. Libertyville, Illinois, US) (Fig. 1a).
Taking into account the presence of phophatidylserine
(PS) residues in MPs surface, events present in Annexin
V+ region were accessed for their positive staining with
annexin V (BD Bioscience). The flow cytometry analysis
done in this study was to verify the presence of Annexin
V+ MPs in the pellet.
Proteomic analysis
One hundred microlitres (100 μl) of frozen MPs frac-
tions were thawed and resuspended in 60% methanol
and 0.1 M ammonium bicarbonate pH 8.0. Incubation
with diothiothreitol followed by cysteine alkylation with
iodoacetamide reduced the proteins. The solution was
incubated overnight with mass spectrometry grade tryp-
sin (Pierce, USA) at 37 °C to digest the proteins. The ob-
tained tryptic peptides underwent desalting using
reversed phase cartridge by washing in 0.5% acetic acid.
The peptides were then eluted with 95% acetonitrile and
0.5% acetic acid. The eluted peptides were lyophilized
and re-suspended in 0.5% acetic acid and directly ana-
lyzed using 2-dimensional liquid chromatography tan-
dem mass spectrometry (2D-LC-MS/MS). The samples
were loaded onto a microcapillary strong cation ex-
change column and fractions were collected using an
increasing salt step elution gradient. Afterwards, each
fraction was analyzed using the LTQ ion trap mass spec-
trometer (Thermo-Fisher Scientific, Waltham, MA). The
Fig 1 The figure shows a Venn diagram depicting overlap in MP proteins
identified in Malaria, Culture Supernatant and Control samples
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acquired MS/MS spectra were searched against protein
database available at www.uniprot.org [19]. The protein
interactions were acquired using the string database
available at http://string-db.org/cgi/.
Western blotting
Experimental Procedures: MPs were thawed and lyzed in
sample buffer and were loaded on SDS-PAGE gels. The
presence of the identified proteins in the samples was
analyzed by Western blot. Bands at the predicted mo-
lecular weight for the proteins were observed [20].
All experiments (both independent and technical)
were repeated 2–4 times.
Data analysis
Proteins identified were analyzed under molecular func-
tion, biological processes, subcellular location and cellu-
lar component using the uniprot database. Resultant
data were further analyzed using SPSS 21.0 statistical
software. Differences between the medians of the various
groups were analyzed by Kruska Willis test. Pairwise
correlations were evaluated with Spearman’s correlation
coefficient r. A p-value < 0.05 was considered to be sta-
tistically significant. For illustration purposes the sam-
ples were categorized into 3 sub-groups according to the
parasitaemia based on the old system of classification (1
+, 2+ and 3+ which corresponded to parasite counts
<5000/μl, >5000/μl but <10,000/μl and parasite count >
10,000/μl respectively in this study) to analyze their as-
sociation with proteins released in MPs.
Results
Participant characteristics
The characteristics of subjects of this study are pre-
sented in Table 1. All patients were reporting on an out-
patient basis. The age range for controls was 28–47
years while the age range for patients was 1 week to
62 years.
Plasmodium (malaria) species
The predominant plasmodium specie found in Ghana is
falciparum. This phenomenon was seen in our study
where all the patients tested had P. falciparum malaria.
Subsequently the MPs types seen also carried P. falcip-
arum markers as well as those of other activated cells
(endothelial cells, erythrocytes, leukocytes and platelets).
Red blood cell indices
The red blood cell indices showed significant variation
between the patients and the control. For example there
was significance in haemoglobin concentration, MCV,
MCH and RDW as seen in Table 2.
Proteomics analysis
A total of 1729 proteins were identified in the malaria
positive samples. The culture supernatant (CSN) showed
333 proteins while a total of 234 proteins were identified
in the control samples. Seventy-two (72) proteins were
common to the malaria positive samples, CSN and the
control. The details are shown in Fig. 1 below.
The mean number of proteins obtained from MPs in
malaria samples was 517.58 ± 56.58 while that of control
was 191.50 ± 5.20. The independent sample t-test
showed significantly higher number of proteins released
in MPs from malaria samples. Twenty-nine P. falcip-
arum proteins were identified in at least one malaria
positive sample (Table 3).
Twenty three (23) RAB proteins were identified in
MPs from malaria samples exclusively without any being
found in the control samples as presented in Table 4.
Out of the 1729 proteins found in the MPs from malaria
positive samples, 653 were identified in plasma MPs
from 1 category of samples only while 1076 proteins
were identified in at least two categories and 697 pro-
teins were found to be common to all 3 categories. The
details of the relationship between the proteins released
in plasma MPs from the 3 categories of malaria positive
samples are shown in Fig. 2 below.
Plasma MPs and inflammation
Some of the proteins identified showed strong link to in-
flammation. Inflammatory proteins seen in malaria MPs
but not control sample MPs include Heat shock protein
Table 1 Patient Characteristics
Control Patients
Number 10 43
Female (%) 50 47.5
Male (%) 50 53.5
Median Age (years) 37.5 (28–47) 22 (0.003–62)
Number below 5 years 0 9
Number pregnant 0 4
Table 2 Red Blood Cell Indices
Parameter (Unit) Control Patients P-value
Mean ± SD Mean ± SD
Hb (g/dl) 13.20 ± 0.94 10.35 ± 2.61 0.037
Hct (%) 36.30 ± 3.35 30.74 ± 8.10 0.184
MCV (fl) 92.95 ± 2.37 80.68 ± 10.75 0.029
MCH (pg) 33.78 ± 0.35 26.82 ± 3.66 0.000
MCHC (g/dl) 35.75 ± 0.64 33.28 ± 2.64 0.072
RBC count (×1012/l) 3.83 ± 0.26 3.86 ± 0.83 0.934
RDW (%) 12.05 ± 0.29 15.80 ± 3.35 0.032
A p-value of < 0.05 was deemed to be statistically significant
Antwi-Baffour et al. Proteome Science  (2017) 15:5 Page 4 of 15
(HSP) 90-alpha, HSP 90-beta, 60 kDa HSP mitochon-
drial, 70 kDa HSP, HSP beta-1, Transforming growth
factor beta-1 induced transcript 1 protein, Macrophage
migration inhibitory factor and Transforming growth
factor beta-1. Again, inflammatory proteins released in
malaria MPs but in reduced quantities included: Heat
shock cognate 71 kDa protein, Heat shock 70 kDa pro-
tein 1A/1B, Heat shock 70 kDa protein 6, Heat shock
70 kDa protein 1-like.
Plasma MPs and the complement system
A good number of complement associated proteins were
seen in the MPs from the malaria samples. It was observed
that the levels of Complement C3 and Complement C4-B,
Complement C5, Complement C9, Complement factor B
and Complement C1q subcomponent subunit C were
significantly elevated in malaria plasma MPs compared to
controls (Table 5).
Plasma MPs and haemostasis
The following proteins associated with coagulation were
release in malaria plasma MPs but not in control plasma.
They are; Thrombospondin-1, Thrombospondin-4,
Coagulation factor V, Coagulation factor XII and Coagula-
tion factor XIII A chain. Again, Fibrinogen beta chain and
plasminogen released in the malaria plasma MPs were
significantly higher compared to control plasma.
There was however no significant difference in levels
of Fibrinogen alpha chain, Fibrinogen gamma chain
and von Willebrand factor between the 2 groups.
Antithrombin-III in plasma MPs was however signifi-
cantly reduced in the patients compared to the con-
trol group. The summary is presented in Table 6.
Table 3 P. falciparum proteins identified in MPs from malaria positive samples
Accession Protein Name Protein MW Species
P04934 Merozoite surface protein 1 196199.8 PLAFC
P08569 Merozoite surface protein 1 193722.4 PLAFM
P13819 Merozoite surface protein 1 193721.5 PLAFF
P19598 Merozoite surface protein 1 192465 PLAF3
P86287 Actin-1 41871 PLAFX
Q8I4X0 Actin-1 41871 PLAF7
P10988 Actin-1 41843 PLAFO
P11144 Heat shock 70 kDa protein 74288 PLAFA
Q00080 Elongation factor 1-alpha 49041.2 PLAFK
P06719 Knob-associated histidine-rich protein 71941.5 PLAFN
P14643 Tubulin beta chain 49751.4 PLAFK
Q7KQL5 Tubulin beta chain 49751.4 PLAF7
P38545 GTP-binding nuclear protein Ran 24875.5 PLAFA
Q27727 Enolase 48704.2 PLAFA
Q8IJN7 Enolase 48678.1 PLAF7
Q9UAL5 Enolase 48662.1 PLAFG
P14140 Tubulin beta chain 49814.4 PLAFA
P13830 Ring-infected erythrocyte surface antigen 124907.8 PLAFF
Q25761 ADP-ribosylation factor 1 20840 PLAFO
Q7KQL3 ADP-ribosylation factor 1 20912 PLAF7
Q94650 ADP-ribosylation factor 1 20912 PLAFA
P12078 Heat shock 70 kDa protein PPF203 (Fragment) 23057.9 PLAFA
P13816 Glutamic acid-rich protein 80551.3 PLAFF
P19260 Merozoite surface antigen 2, allelic form 2 28555.5 PLAFG
P19599 Merozoite surface antigen 2 27890.3 PLAFF
P50490 Apical membrane antigen 1 71968.2 PLAFG
Q03498 V-type proton ATPase catalytic subunit A 68577 PLAFA
P06916 300 kDa antigen AG231 (Fragment) 33968.1 PLAFF
P04928 S-antigen protein 33695.1 PLAFN
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Plasma MPs and haemoglobin sub-units
Some haemoglobin subunit proteins were seen in the
circulating MPs from both malaria positive samples and
controls. The quantities of haemoglobin subunits in
plasma MPs from malaria positive samples were
however significantly higher as compared to controls
(Table 7).
Plasma MPs and adhesive proteins
Some adhesive and receptor proteins were identified in
the plasma MPs from the malaria samples but they were
absent in the control samples. They include: Merozoite
surface protein 1, Knob-associated histidine-rich protein,
Disintegrin and metalloproteinase domain-containing
protein-10,-12,-17, Complement receptor type 1,
Cysteine and glycine-rich protein 1, Ring-infected
erythrocyte surface antigen, Glycophorin-binding
protein, Intercellular adhesion molecule 2, A disintegrin
and metalloproteinase with thrombospondin motif 13,
Merozoite surface antigen 2, Endothelial cell-selective
adhesion molecule.
Plasma MPs and cytoskeletal proteins
Cytoskeletal proteins were identified in the malaria sam-
ples but they were absent in the control samples.
Spectrin alpha chain, erythrocytic 1, Spectrin beta chain
erythrocytic 1, Coronin 1A, Coronin 1C, Myosin 9,
Actin-1, Actin-related protein 3, Actin-related protein 2,
Actin-related protein 2/3 complex subunit 3, Actin-
related protein 2/3 complex subunit 4 and Actin-related
protein 2/3 complex subunit 5.
Flow cytometer distribution for MPs show a typical
forward-/side-scatter distribution
MPs can be identified by their forward-/side- scatter ap-
pearance on flow cytometer. As can be seen from Fig. 3,
the forward/side scatter distribution of the MPs from
the samples shows a similar pattern in line with the clas-
sical appearance of MPs on flow cytometer and compar-
able to those obtained by others in similar experiments.
This, in combination with other properties such as the
proteins detected give credence to the fact that through-
out our experiments, MPs were being obtained.
Protein enrichment of the isolated MPs
Figure 4 shows protein enrichment of MPs (A) and pro-
teins differentially expressed by MPs (B) by Western
blot. The proteins were loaded according to the sample
categories of mild, moderate and high malaria as well as
no-malaria and bands at the predicted molecular weight
for each of the proteins were observed.
Correlation coefficient of clinical variables
Tables 8, 9 and 10 show the Spearman correlation coeffi-
cients of various groups of proteins identified in MPs from
malaria samples against the parasite count and peripheral
haemoglobin concentration. There was no significant cor-
relation of all the haemoglobin subunits against either the
peripheral haemoglobin concentration or parasite count.
Table 4 List of Rab Proteins identified in MPs isolated from
malaria samples
Accession Protein Name Protein MW Species
Q9H0U4 Ras-related protein Rab-1B 22171.4 HUMAN
O00194 Ras-related protein Rab-27B 24608.1 HUMAN
P62820 Ras-related protein Rab-1A 22678 HUMAN
P61006 Ras-related protein Rab-8A 23668.4 HUMAN
P61106 Ras-related protein Rab-14 23897.2 HUMAN
P61026 Ras-related protein Rab-10 22541.1 HUMAN
P31150 Rab GDP dissociation inhibitor alpha 50583.2 HUMAN
P51149 Ras-related protein Rab-7a 23490 HUMAN
Q92930 Ras-related protein Rab-8B 23584.3 HUMAN
Q9NRW1 Ras-related protein Rab-6B 23461.9 HUMAN
P62491 Ras-related protein Rab-11A 24393.7 HUMAN
P50395 Rab GDP dissociation inhibitor beta 50663.7 HUMAN
Q15286 Ras-related protein Rab-35 23025.4 HUMAN
P20340 Ras-related protein Rab-6A 23593 HUMAN
P51148 Ras-related protein Rab-5C 23482.8 HUMAN
P51153 Ras-related protein Rab-13 22774.3 HUMAN
Q13637 Ras-related protein Rab-32 24997.5 HUMAN
Q96AX2 Ras-related protein Rab-37 24815.4 HUMAN
Q96E17 Ras-related protein Rab-3C 25952.4 HUMAN
Q9UL25 Ras-related protein Rab-21 24347.8 HUMAN
P61020 Ras-related protein Rab-5B 23707 HUMAN
P61019 Ras-related protein Rab-2A 23545.8 HUMAN
Q9NP72 Ras-related protein Rab-18 22977.3 HUMAN
Fig. 2 A Venn diagram depicting overlap of MP proteins identified
in the 3 categories of malaria samples
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Peripheral haemoglobin however negatively correlated with
parasite count (r = −0.415, p < 0.001) and Mannose-binding
lectin serine protease 2 (r = −0.664, p < 0.001) while it posi-
tively correlated with Complement C3 (r = 0.457, p < 0.001).
Parasite count correlated negatively with Complement C3
(r = −0.359, p < 0.05) and correlated positively with Com-
plement C1s subcomponent (r = 0.407, p < 0.001) and C4b-
binding protein beta chain (r = 0.845, p < 0.05).
Discussion
The study identified an array of proteins from the MPs
isolated from the malaria positive samples, culture super-
natant and healthy controls. The mean haemoglobin (Hb)
of the studied subjects was significantly lower than that
of the control group (p = 0.037). This finding agrees
with a study in the Brazilian Amazon in which out of a
total of 7831 people studied, individuals with malaria
were seen to have the lowest Hb compared to commu-
nity controls and malaria-negative febrile patients [21].
The results of our study also collaborate with the
results from a study carried out in Nigeria [22]. These
observations are expected because, as far back as in
1947 the plasmodium was reported to “consume”
haemoglobin during its growth within erythrocytes
[23]. P. falciparum for instance is capable of digesting
more than 80% of the erythrocyte haemoglobin [24].
Table 5 Analysis of complement proteins from samples
Parameter Patients Control P-value
Non-Parametric Median (Q1-Q3) Median (Q1-Q3)
Complement C3 192.5 (181–204) 134 (88–183) 0.083
Complement C4-B 103 (96–110) 38 (23–60) 0.000
C4b-binding protein alpha chain 18.5 (18–19) 15 (10.25–19.75) 0.192
Complement C1r subcomponent 15.5 (12–19) 16.5 (6.75–24.25) 0.895
Complement C1s subcomponent 9 (5–13) 6 (4–11.75) 0.311
Complement C5 11 (9–13) 4 (2–8) 0.620
Complement C1q subcomponent subunit B 3.5 (3–4) 5 (3–7) 0.142
Complement component C9 23 (21–25) 11 (7–18) 0.000
Complement factor B 11.5 (8–15) 5 (3–9.75) 0.025
Complement factor H 12.5 (5–20) 5 (2–10) 0.150
Complement C1q subcomponent subunit A 2 (1–4) 3 (2–5) 0.315
Complement C1q subcomponent subunit C 4 (2–6) 2 (1–3) 0.035
Complement component C7 6 (4–8) 2 (1.75–4) 0.061
Parametric Mean ± SD Mean ± SD
Complement component C6 4.27 ± 0.43 1.33 ± 0.52 0.000
A p-value of < 0.05 was deemed to be statistically significant
Table 6 Analysis of haemostatic proteins from samples
Parameter Control Patient P-value
Non-Parametric Median (Q1-Q3) Median (Q1-Q3)
von Willebrand factor 11.5 (11–12) 15 (5.5–27) 0.493
Antithrombin-III 17 (13–21) 5.5 (3–8) 0.001
Thrombospondin-1 39 (17.25–71.25) 0 0.000
Coagulation factor V 16.50 (5.25–36.50) 0 0.000
Coagulation factor XIII A chain 8 (1–19) 0 0.000
Thrombospondin-4 0.00 (0–3.75) 0 0.043
Coagulation factor XII 1 (0–2) 0 0.004
Plasminogen 30.0 (10.25–43.75) 0 0.000
Parametric data Mean ± SD Mean ± SD
Fibrinogen alpha chain 88.5 ± 0.58 59.01 ± 28.35 0.045
Fibrinogen beta chain 74.13 ± 6.93 56.79 ± 27.62 0.225
Fibrinogen gamma chain 53.37 ± 9.24 37.56 ± 16.05 0.066
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This goes to explain the significant negative correl-
ation of Hb and parasite count (r = −0.415, p < 0.001)
indicating that the greater the parasite density in a
patient the lower the Hb, as was also reported in a
study in Thailand [25].
Again, there was a reduction of the haematocrit (Hct)
of the patients (Table 2) as compare to controls which
was however not significant. Similar results were re-
ported in patients with uncomplicated malaria where the
authors indicated that, uncomplicated malaria was
Table 7 Analysis of haemoglobin subunit proteins in samples
Parameter Control Patients P-value
Median (Q1-Q3) Median (Q1-Q3)
Haemoglobin subunit gamma-2 1 (1–1) 23 (10–63) 0.001
Haemoglobin subunit beta 13 (11–15) 143 (69–274) 0.000
Haemoglobin subunit gamma-1 1 (1–1) 28 (10.5–64.5) 0.000
Haemoglobin subunit alpha 11 (9–13) 125 (52–284) 0.000
Haemoglobin subunit delta 3.5 (3–4) 72 (40–138) 0.000
Haemoglobin subunit epsilon 1 (1–1) 21 (8–51) 0.000
Fig. 3 Read out from flow cytometry depicting the classical appearance of MPs
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associated with milder biochemical alteration and haem-
olysis as opposed to complicated/severe malaria [26]. A
study done at ECWA Community Health Centre,
Bukuru, Jos in Nigeria however showed significant re-
duction of the haematocrit of malaria samples compared
to healthy controls [22].
The mean cell volume (MCV) of the patients was sig-
nificantly lower than that of the control group (Table 2).
This result was unexpected because previous studies in a
population near Thailand-Myanmar border indicated the
Fig. 4 A figure showing protein enrichment of MPs a and proteins differentially expressed by MPs b through western blotting. The proteins were
loaded according to the sample categories of mild, moderate and high malaria as well as no malaria and bands at the predicted molecular
weight for each of the proteins were observed. The figure shows representative gels of 2–4 experiments
Table 8 Spearman’s rank correlation coefficients of Haemoglobin
subunits and coagulation proteins released in MPs against peripheral
haemoglobin concentration and parasite count
Microparticle Protein HB Parasite Count
HB −0.415**
Haemoglobin subunit epsilon 0.2 −0.25
Haemoglobin subunit gamma-2 0.201 −0.227
Haemoglobin subunit beta −0.063 0.085
Haemoglobin subunit gamma-1 0.197 −0.17
Haemoglobin subunit alpha −0.09 0.212
Haemoglobin subunit delta −0.059 0.13
Haemoglobin subunit mu −0.5 0.5
Alpha-Haemoglobin-stabilizing protein 0.5 −0.5
Fibrinogen beta chain 0.211 −0.254
Fibrinogen alpha chain 0.029 0.121
Fibrinogen gamma chain 0.285 −0.131
Coagulation factor V 0.177 −0.151
Coagulation factor XIII A chain 0.053 0.037
von Willebrand factor 0.036 0.047*
Antithrombin-III 0.175 −0.079
Coagulation factor XII 0.2 −0.006
*Correlation significant at p < 0.05
**Correlation significant at p < 0.001
Table 9 Spearman’s rank correlation coefficients of Complement
proteins released in MPs and peripheral haemoglobin concentration
and parasite count
Complement Proteins HB Parasite Count
Complement C4-B 0.21 −0.161
Complement component C6 −0.207 −0.414
Complement C3 0.457** −0.359*
C4b-binding protein alpha chain 0.095 0.103
Complement C1r subcomponent 0.006 0.045
Complement C1s subcomponent −0.081 0.407**
Complement C5 −0.017 0.025
Complement C1q subcomponent subunit B 0.147 −0.191
Complement component C9 0.045 −0.111
Complement factor B 0.007 0.144
Complement factor H 0.078 −0.004
Complement C1q subcomponent subunit A −0.071 0.352
Complement C1q subcomponent subunit C 0.124 −0.224
Complement component C8 beta chain 0.202 0.251
Complement component C7 0.025 0.350
Complement factor I −0.059 −0.736
Complement component C8 alpha chain 0.421 0.089
Complement component C8 gamma chain −0.344 0.465
Complement decay-accelerating factor −0.514 0.062
C4b-binding protein beta chain −0.338 0.845*
Complement factor H-related protein 2 −0.258 0.775
Complement factor I −0.059 −0.736
Complement component C8 alpha chain 0.421 0.089
Complement component C8 gamma chain −0.344 0.465
*Correlation significant at p < 0.05
**Correlation significant at p < 0.001
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opposite finding usually because as erythrocytes are be-
ing destroyed in malaria infection, the bone marrow is
stimulated to push more new erythrocytes whose mean
cell volume are higher than older erythrocytes [25]. Also,
the mean cell haemoglobin (MCH) of patients was sig-
nificantly lower than that of the control group. This re-
sult however contradicts with the results of the
population near the Thailand-Myanmar border where
the predominant malaria parasite is P. vivax [25]. There-
fore the results seen in this study can probably be ex-
plained by the ability of P. falciparum (predominant in
Ghana) to consume haemoglobin during its growth in
the erythrocyte [23] and the propensity of the erythro-
cytes in malaria to release more haemoglobin-bearing
MPs into circulation leaving the erythrocytes with less
haemoglobin compared with erythrocytes from healthy
controls [23].
The red cell distribution width (RDW) was signifi-
cantly higher (p = 0.032) in the patients compared to the
control group. It was however consistent with results
from a P. vivax malaria study [27]. The mean RDW was
15.80 and RDW greater than 15 has been shown to be a
predictive value of malaria infection, although some re-
searchers contest this [28, 29]. In P.vivax malaria how-
ever, the elevated RDW results from the initial size
increase of parasitized erythrocytes which is followed by
erythrocyte rapture. The same mechanism however can-
not be said to be associated with RDW increase in P. fal-
ciparum infection since parasitized cells maintain their
sizes [29]. The elevated RDW seen in this study could
result from the bone marrow’s effort to balance erythro-
cytes loss in malaria by pushing more new erythrocytes
into circulation which also increases the macrocyte per-
centage [30, 31].
Again, our data indicated that a significantly higher
amount of all haemoglobin subunits released came from
MPs of malaria positive samples. This point to an inter-
esting phenomenon where the erythrocytes from malaria
patients lose their haemoglobin to vesiculation and the
vesicles that result may be eliminated by the body
thereby contributing to anaemia. Table 3 shows a list of
24 RAB proteins found in the malaria samples. They in-
clude proteins which play pivotal roles in relation to MP
docking, fusion and appropriate targeting of various cel-
lular compartments [32].
Also, among the proteomics data were some erythro-
cyte cytoskeletal proteins which have been referred to as
low abundance cytoskeletal proteins [33]. They include
myosin chains, moesin, ezrin and F-actin capping pro-
teins. Furthermore, some Pf proteins which have been
described as potential drug targets were identified in the
MPs, they include: enolase, Hsp 90, hypoxanthine guan-
ine phosphoribosyl transferase, L-lactate dehydrogenase
and Phosphoglycerate kinase. This is because the para-
site through these proteins in their pathways starts pro-
cesses such as glycolysis, haemoglobin digestion and
salvage of purines [34]. Tubulin Beta which is a brain
antigen that can discriminate cerebral malaria from
other forms of the disease was identified in MPs from 38
samples [35]. This protein chain is an antimalarial target
[36].
Enolase is a glycolytic enzyme and especially essential
in ATP generation in organisms that are devoid of the
Krebs cycle. In malaria, surface enolase assists in para-
site invasion by binding to plasminogen [37]. Enolase
was found in MPs of 38 of the samples. It is known to
play a crucial role in the parasite invasion of the midgut
of the mosquito [38]. A study has shown that its levels
are elevated in infected red blood cells compared to un-
infected cells. Antibodies against merozoite surface eno-
lase have the ability to interfere with P. falciparum
invasion of the red cell thereby conferring a partial pro-
tection against malaria [39]. Knob-associated histidine-
rich protein (KAHRP) was identified in only 1 of the 43
malaria samples. KAHRP is a major component of the
knob which is an electron-dense protrusion located on
the membrane of infected erythrocytes. The knob is the
site of adhesive interaction between infected erythro-
cytes and vascular endothelial cells [40].
Plasmodium falciparum Merozoite surface protein 1
(MSP-1) which is also called precursor to major merozo-
ite surface antigens (PMMSA) or merozoite surface anti-
gen 1 (MSA-1) was identified in MPs from 2 of the
malaria samples [41]. This protein is the most widely
studied of proteins of Plasmodium falciparum. MSP-1 is
well conserved among P. falciparum isolates and hence
it was identified in the MP isolated from the culture
supernatant [42]. This protein binds to erythrocytes in a
sialic dependent manner suggesting it is a receptor to a
ligand on erythrocyte surface permitting adhesion of
Plasmodium falciparum [41].
Also, merozoite surface antigen 2 (MSP2) which is a
surface coat protein essential for the survival of the
blood-stages of P. falciparum was identified [43]. This
Table 10 Spearman’s rank correlation coefficients of selected
microparticle proteins against Parasite count and Haemoglobin
Microparticle Protein HB Parasite Count
Leukocyte elastase inhibitor −0.106 −0.206
P-selectin 0.078 −0.023
Mannan-binding lectin serine protease 2 −0.664** 0.176
Intercellular adhesion molecule 1 −0.686 0.169
Intercellular adhesion molecule 2 −0.093 −0.109
Intercellular adhesion molecule 3 −0.726* 0.676
Mannan-binding lectin serine protease 1 −0.157 0.258
*Correlation significant at p < 0.05
**Correlation significant at p < 0.0
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protein and its allelic form 2 were identified in MPs
from one sample. Also identified in one sample was
Plasmodium falciparum Apical membrane antigen 1
(PfAMA1) which is synthesized during schizogony and
transported to micronemes. PfAMA1 translocates onto
the merozoite surface prior to erythrocyte invasion when
it serves as an adhesion molecule playing a central role
in the invasion process [44]. Ring-infected erythrocyte
surface antigen (RESA), a protein expressed in early
stage gametocytes, final stages of schizont and stored in
dense granules within the merozoites was found in one
sample. RESA binds to spectrin, its primary site on
erythrocyte and is associated with the membrane of re-
cently invaded erythrocyte but it is only evident in the
cell up to 24 h after parasite invasion [45].
Glutamic acid-rich protein (GLURP) found in one
sample is a molecule located on the surface of merozo-
ites and also in the hepatic stage [46]. This protein is an
antigen and its epitopes defined by non-repetitive se-
quence are thought of to be more effective antibody-
dependent cellular inhibition process and is believed to
be involved in acquired protective immunity to malaria.
These epitopes are therefore proposed to be preferred in
vaccine formulations against malaria [47, 48]. Also, P.
falciparum actin 1(PfACT1) was expressed in the MPs
of 35 samples. PfACT1 is a ubiquitously expressed pro-
tein and it is expressed throughout the lifecycle of the
Plasmodium. However, its isoform PfACT 2 which is
expressed only in the sexual stages of the parasite was
not isolated in any of the samples [49].
Heat shock 70 kDa protein (Hsp70) was expressed in
35 samples. P. falciparum has six Hsp70s [50]. Hsp70
proteins have molecular chaperone functions, and are
involved in a number of processes including protein deg-
radation and controlling of the activity of regulatory pro-
teins, protein folding and protein translocation across
membranes. Hsp 70 members are present in almost all
cellular compartments [51] and this could account for
its identification in a good number of our samples. Also,
elongation factor-1 alpha was found in the MPs from 7
of the malaria positive samples. It is an abundant protein
that is an essential element in eukaryotic protein transla-
tion, in species of Plasmodium [52]. It is key in the pro-
liferation of the blood stages of Plasmodium [53].
Precursors of serine-repeat antigen (SERA) proteins
are synthesized in the late trophozoites [54]. Among or-
ganisms in the apicomplexan phylum and with the ex-
ception of Theileria found in cattle, species of
Plasmodium are the only organisms that the gene family
translating into Serine-repeat antigen (SERA) protein
has been found [55]. This protein was found in 1 sam-
ple. Investigation with anti-SERA antibody has estab-
lished SERA protein as a target for antibody dependent
cellular inhibition of P. falciparum development [56].
Also identified was Plasmodium falciparum ADP-
ribosylation factor 1 (PfARF1) which is activated after
binding to GTP. In the secretary pathway, PfARF1 regu-
lates vesicular biogenesis and trafficking processes [57]. It
is also thought of to be involved in the transport of MSP-1
from the endoplasmic reticulum and plays a role in the ac-
tivation of a calcium-signalling mechanism in the parasite
[58]. Hypothetical protein identified 300 kDa antigen
AG231 (Fragment) was also found in 1 sample. This
protein was discovered in about 93% of 65 patients living
in a malaria endemic area in Papua Guinea. It is found in
schizonts and trophozoites. Again, P. falciparum S-
antigen proteins were found in the MPs of 2 samples.
They are heat-stable antigens that are serologically diverse
among varied isolates of the parasite [59].
There was significant difference in the levels of the fol-
lowing complement system proteins released in plasma
circulating MPs between the malaria samples and that of
control: complement component C6, complement C4-B,
complement component C9, complement factor B and
Complement C1q subcomponent subunit C. The differ-
ence between the patients and the control group in
complement component C3 was however not significant
but correlation analysis indicated a significant negative
correlation between C3 released in MPs and parasite
count in the malaria samples. There was significant posi-
tive correlation between C3 and haemoglobin (r = 0.457).
It is known that MPs are able to bind to complement
component C1q and cause the C3 to be fixed on the
MPs after exposure to normal human serum through
the classical pathway. These complement-fixed MPs are
capable of binding to erythrocytes and remove them
from circulation [60]. It could therefore be presumed
that complement-fixed MPs bound to erythrocyte might
be a mechanism that explains the increase erythrocyte
clearance in malaria leading to reduced haemoglobin
concentration. This presumption can be related to a
similar work that explains the role of MPs in comple-
ment activation relating to the pathogenesis of rheuma-
toid arthritis [61].
Also, Hb negatively correlated with Mannan-binding
lectin serine protease 2 released in MPs (Table 10).
This may be explained by the ability of this protein
to activate complement and interact with phagocytes
and also serves as an opsonin to Plasmodium infected
erythrocytes facilitating the elimination of such eryth-
rocytes from circulation and invariably causing reduc-
tion in Hb [62].
C4 binding protein beta chain in MPs from malaria
samples correlated positively with parasite count. C4
binding protein is an abundant plasma protein whose
natural function is to inhibit the classical and lectin
pathways of complement activation. Research has shown
that the fusion of oligomerization domains of C4 binding
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protein to MSP-1 from Plasmodium yoelii improved its
immunogenicity [63]. C4 binding protein beta chain
released in MPs could hence be acting as an adjuvant to
MSP-1 antigens thereby eliciting the appropriate im-
mune response against the parasite. Antithrombin con-
centration with the MPs in the patients was significantly
low compared with the controls [64]. Serum concentra-
tion of antithrombin III particularly in severe malaria is
reduced [65, 66]. This is because generally malaria is
associated with the consumption of Antithrombin [67].
Figures 5 and 6 represent isolated proteins that are
involved in biological and molecular functions, Fig. 7
represent isolated proteins that are cellular components
and Fig. 8 a network model delineating the P. falciparum
proteins isolated from MPs of malaria positive samples
and their associated pathways.
In terms of limitations, because convenience sampling
was used in this study further stratification of the pa-
tients and control was not done to assess the association
of parameters like age category, sex and duration of on-
set of symptoms on the proteomic profile of subjects. If
possible, a further prospective sampling involving sex
and age matched controls should be employed in future
study so that data could be stratified to address the
afore-mentioned limitation.
Conclusion
Our study has clearly established that there is an up
regulation of protein content of circulating plasma MPs
from malaria patients than in healthy controls. A great
variety of protein content can be seen in malaria patients
although a large number of proteins identified were
common to the 3 categories of malaria samples. Further-
more, higher amounts of haemoglobin subunits are re-
leased into circulating MPs of malaria patients. These
MPs when finally eliminated from circulation have the
propensity to cause anaemia. Interaction enrichment in-
dicates that the P. falciparum proteins isolated from the
malaria samples are least partially connected as a group.
The protein-protein interaction (PPI) of the inter-
action of the P. falciparum indicated that the proteins
have more interactions among themselves than what is
expected for a random set of proteins of similar size
drawn from the P. falciparum genome. The enrichment
indicates the proteins are at least partially connected as
a group.
Fig. 5 3D pie chart of the Gene Ontology of all P. falciparum proteins isolated from samples that are involved in biological processes
Fig. 6 3D pie chart of Gene Ontology of the P. falciparum proteins isolated from the malaria samples that are involved in molecular functions
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Fig. 7 3D pie chart of Gene Ontology of P. falciparum proteins isolated in the malaria samples that are cellular components
Fig. 8 A network model delineating the P. falciparum proteins isolated from the MPs in malaria positive plasma and their associated pathways.
The node colours represent MP proteins and their interactions (colour coded basis for a particular interaction)
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